Astellas Pharma Inc (STU:YPH)
€ 11.4 +0.10 (+0.88%) Market Cap: 20.87 Bil Enterprise Value: 22.37 Bil PE Ratio: 13.32 PB Ratio: 2.12 GF Score: 83/100

Q2 2026 Astellas Pharma Inc Earnings Presentation Transcript

Oct 30, 2025 / NTS GMT
Release Date Price: €8.84 (+0.96%)

Oct 30, 2025 / NTS GMT
Presentation
Oct 30, 2025 / NTS GMT

=====================
Corporate Participants
=====================
* Nobuko Kato
Astellas Pharma Inc - Chief Communications & IR Officer
* Naoki Okamura
Astellas Pharma Inc - President, Chief Executive Officer, Representative Director
* Tadaaki Taniguchi
Astellas Pharma Inc - Chief Research and Development Officer
* Claus Zieler
Astellas Pharma Inc - Chief Commercial & Medical Affairs Officer
* Atsushi Kitamura
Astellas Pharma Inc - Senior Managing Executive Officer, Chief Financial Officer

=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Global Markets Japan Inc - Analyst
* Seiji Wakao
JPMorgan Securities Japan Co Ltd - Analyst
* Akinori Ueda
Goldman Sachs Japan Co Ltd - Analyst
* Hiroyuki Matsubara
Nomura Securities International Inc - Analyst
* Fumiyoshi Sakai
UBS Securities Japan Co Ltd - Analyst
* Shinichiro Muraoka

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot